DOCSLIB.ORG

United States Patent (19) 11 Patent Number: 5,939,095 Hille Et Al

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
United States Patent (19) 11 Patent Number: 5,939,095 Hille Et Al USOO5939.095A United States Patent (19) 11 Patent Number: 5,939,095 Hille et al. (45) Date of Patent: Aug. 17, 1999 54) TRANSDERMAL THERAPEUTIC SYSTEM 5,106,831 4/1992 Fisher .......................................... 514/2 AND A PROCESS FOR THE COMBINED 5,364,629 11/1994 Kochinke ... 424/449 TRANSIDERMAL APPLICATION OF 5,391,375 2/1995 Hille ........................................ 424/449 PHYSOSTIGMINE AND SCOPOLAMINE FOR FOREIGN PATENT DOCUMENTS THE PROPHYLAXIS AND PRETREATMENT OF A POSONING CAUSED BY HIGHLY 3 315 272 3/1986 Germany. TOXC ORGANOPHOSPHORUS 3 843 239 2/1990 Germany. NEUROTOXINS IN PARTICULAR SOMAN 4 115 558 11/1992 Germany. OTHER PUBLICATIONS 75 Inventors: Thomas Hille; Walter Miller, both of Neuwied; Bodo Asmussen, Ammersbek, Can. J. Physiol. and Pharmacol., Effects of subchronic all of Germany pyridostigmine pretreatment on the toxicity of Soman, J. D. Shiloff, et al. vol. 64, pp. 1047-1049, 1986. 73 Assignee: LTS Lohmann Therapie-Systeme Gov. Rep. Announce Index, Comparing the Efficacy of GmbH, Neuwied, Germany PhySoStigmine pretreatment in combination with Scopola 21 Appl. No.: 08/656,208 mine verSuS Artane against Soman Challenge, R.P. Solana, et al, vol. 89, No. 15, abstract 942,440, 1989. 22 PCT Filed: Dec. 6, 1994 Leadbetter, “When all else fails”, Chemistry in Britain, Jul. 1988 pp. 683–688. 86 PCT No.: PCT/EP94/04.048 Fleisher et al., “Dealkylation ASA Mechanism For Aging of S371 Date: Jul. 30, 1996 Cholinesterase After Poisoning With Pinacolyl Meth ylphosphonofluoridate” Biochemical Pharmacology, 1965, S 102(e) Date: Jul. 30, 1996 vol. 14, pp. 641-650. 87 PCT Pub. No.: WO95/15755 Berry et al., “The Use of Carbamates And Atropine In The Protection of Animals Against Poisoning By 1.2.2-Trimeth PCT Pub. Date:Jun. 15, 1995 ylpropyl Methylphosphonofluoridate” Biochemical Pharma 30 Foreign Application Priority Data cology, vol. 19, pp. 927–934 (1990). Dec. 10, 1993 DEI Germany .......................... P 4342 174 Primary Examiner D. Gabrielle Brouillette Attorney, Agent, or Firm Wenderoth, Lind & Ponack, (51 Int. Cl. ................................................ A61F 13/00 LLP. 52 U.S. Cl. .................. ... 424/449; 424/448 58 Field of Search ...................................... 424/448, 449 57 ABSTRACT A transdermal therapeutic System for the prophylaxis and 56) References Cited pretreatment of a poisoning caused by highly toxic organo U.S. PATENT DOCUMENTS phosphorus neurotoxins is characterized in that it has a pharmaceutical formulation with an active Substance com 3,742,951 7/1973 Zaffaroni ................................. 128/268 bination consisting of at least one parasympathomimetically 3,797,494 3/1974 Zaffaroni ...... ... 128/268 active Substance and at least one parasympatholytically 3.996,934 12/1976 Zaffaroni .......... ... 128/268 active Substance. 4,031,894 6/1977 Urquhart et al. ... 128/268 4,981,858 1/1991 Fisher ... ... 514/278 5,089,267 2/1992 Hille ........................................ 424/449 6 Claims, 1 Drawing Sheet 2 5,939,095 1 2 TRANSIDERMAL THERAPEUTIC SYSTEM immediately on occurrence of the first Symptoms of the AND A PROCESS FOR THE COMBINED poisoning. The requirement with respect to the carbamate TRANSIDERMAL APPLICATION OF used in the pretreatment is that it should not have significant PHYSOSTIGMINE AND SCOPOLAMINE FOR undesired effects at the highest possible, lasting protective THE PROPHYLAXIS AND PRETREATMENT action, in particular it must not impair reaction capacity. OF A POSONING CAUSED BY HIGHLY Some of the organophosphorus cholinesterase inhibitors TOXC ORGANOPHOSPHORUS are distinguished by the fact that they split off alkyl residues NEUROTOXINS IN PARTICULAR SOMAN after accumulation to the acetylcholinesterase, thus Stabiliz ing the bond (“aging”). The aged esterase inhibitor complex This application is a 371 of PCT/EP94/04048, filed Dec. cannot be reactivated by Oximes. In case of poisonings 6, 1994. caused by the nerve warfare agent Soman, aging already The present invention relates to a transdermal therapeutic occurs after 2 to 5 minutes. The therapy with atropine and System and to a proceSS for the combined transdermal Oximes can considerably be improved by a preliminary application of phySoStigmine and Scopolamine for the pro treatment with indirect parasympathomimetics, e.g., car phylaxis and preliminary treatment of poisoning caused by 15 bamic acid esters, Such as pyridostigmine and phySoStig highly toxic organophosphorus cholinesterase inhibitors, in C. particular Soman. In particular, the present invention is to Carbamic acid esters inhibit the acetylcholinesterase in a provide pharmaceutical formulations releasing Suitable manner Similar to that of phosphoric acids. However, the active Substances without detrimental side effects in a con bond is of a shorter duration and completely reversible. The trolled manner for the prophylactic treatment of poisonings fact that the carb amates inhibit part of the caused by organophosphorus cholinesterase inhibitors. acetylcholinesterase, if dosed Suitably, and thus remove it from the reach of the phosphoric esters and phosphonates BACKGROUND OF THE INVENTION having a stronger and prolonged inhibition may well be a The group of organophosphorus cholinesterase inhibitors decisive factor for their protective action, provided that the include certain esters of phosphoric acid derivatives, e.g., 25 pretreatment started in time. nitrostigmine (=diethyl-(4-nitrophenyl)-thiophosphate), bet Also, the treatment of poisoning caused by phosphoric ter known under the names Parathion or E 605, but they also insecticides requires prompt medical care in any case. Since include tabun, as well as the phosphonic acid derivatives medical care in case of harvesters cannot always be accom Sarin, Soman and VX. plished promptly, there is a need for drugs prophylactically Among other things cholinesterase-inhibiting phosphoric counteracting an intoxication. The use of carbamic acid esters are used as insecticides in agriculture. Since they have esters for this purpose has already been described a toxic effect on human beings too, the Staff working in (Leadbeater, L. Chem. in Brit. 24, 683, 1988). The same agriculture is Subject to a basic hazard to life and limb; this applies to the effectiveness of carbamic acid esters in the pretreatment of a Soman poisoning in animal experiments is true all the more since these organic phosphoric esters can 35 also be absorbed via the skin. AS compared to insecticides, (Fleischer, J. H., Harris, L. W. Biochem. Pharmacol. 14,641, the compounds tabun, Sarin, Soman and VX which belong to 1965; Berry, W. K., Davies, D. R. Biochem. Pharmacol. 19, the group of the So-called nerve warfare agents are distin 927, 1970). The effective dosage of drugs to be applied guished by a particularly high toxicity. All of these com prophylactically should not impair reactivity and functional pounds are more or le SS Strong inhibitors of capacity. However, carbamic acid esters have a low thera acetylcholinesterase, an enzyme which physiologically 40 peutic index. AS compared to pyridoStigmine, an increased blocks the effect of the transmitter acetylcholine released at protective action can be achieved by physostigmine, certain nerve endings. Most of the Symptoms of poisoning however, the Side effects are more Severe. caused by cholinesterase inhibitors are produced by an On principle, undesired parasympathomimetic effects of inundation with endogenic acetylcholine. 45 the carbamates can be repressed by combinations with a The basic drug therapy of Such a poisoning consists in the parasympatholytic (e.g., atropine, Scopolamine). administration of the parasympatholytic atropine, blocking DE-OS 41 15 558 describes a prophylactic antidote the exceeding muscarinic acetylcholine effects (e.g., consisting of a combination of pyridoStigmine or phySOS increase of Secretion in the respiratory System, tigmine and N-methyl-4-piperidyl-1-phenylcyclopentane bronchoSpasm, inhibition of the central nervous respiratory 50 carboxylate-hydrochloride or arpenal, Sycotrol, carmiphene drive). There is no Suitable antagonist available to normalize orbenactyzine, and, as an additional compelling component, the exceeding nicotinic acetylcholine actions (e.g., inhibi a tranquilizer, i.e., diazepam or clonazepam. The undesired tion of the impulse transmission at the Synapses of motorial effects of phySoStigmine or pyridoStigmine can therefore not nerves to the respiratory musculature and to other skeletal be Suppressed by the mentioned parasympatholytics alone, muscles up to a complete peripheral motor paralysis). The 55 for this reason tranquilizers are additionally administered, peripherally caused myoparesis can only be compensated by whose side effects are problematic too. Oximes, e.g., pralidoxime (PAM) or obido Xime Accordingly, it is necessary to allow the prophylactic (Toxogonine) whose mechanism of action consists in a administration of carbamic acid esters or other indirect reactivation of the inhibited acetylcholinesterase. parasympathomimetics at a dosage causing a Sufficient pro However, this post-exposure therapy is not Sufficient to 60 tection against organophosphorus cholinesterase inhibitors ensure Survival after poisoning with the double LDs of without undesired accompanying effects. Soman (LDso=dose which is lethal for 50% of the exposed Subjects). The probability of Survival after a Soman poison DESCRIPTION OF THE INVENTION ing increases only when a pretreatment with a carbamate, It is the object of the present
Load more

Recommended publications
  • Efficacy of Trimedoxime in Mice Poisoned with Dichlorvos, Heptenophos Or Monocrotophos
    CORE Metadata, citation and similar papers at core.ac.uk Provided by FarFar - Repository of the Faculty of Pharmacy, University of Belgrade C Basic & Clinical Pharmacology & Toxicology 2005, 96, 111–117. Printed in Denmark . All rights reserved Copyright C ISSN 1742-7835 Efficacy of Trimedoxime in Mice Poisoned with Dichlorvos, Heptenophos or Monocrotophos Biljana Antonijevic´1, Dubravko Bokonjic´2, Milosˇ P. Stojiljkovic´2, Vesna Kilibarda2, Zoran A. Milovanovic´2, Mirjana Nedeljkovic´1 and Matej Maksimovic´1 1Institute of Toxicological Chemistry, School of Pharmacy, University of Belgrade, Vojvode Stepe 450, and 2National Poison Control Centre, Military Medical Academy, Crnotravska 17; 11000 Belgrade, Serbia and Montenegro (Received June 18, 2004; Accepted September 3, 2004) Abstract: The aim of the study was to examine antidotal potency of trimedoxime in mice poisoned with three direct dimethoxy-substituted organophosphorus inhibitors. In order to assess the protective efficacy of trimedoxime against dichlorvos, heptenophos or monocrotophos, median effective doses and efficacy half-times were calculated. Trimedoxime (24 mg/kg intravenously) was injected 5 min. before 1.3 LD50 intravenously of poisons. Activities of brain, diaphragmal and erythrocyte acetylcholinesterase, as well as of plasma carboxylesterases were determined at different time intervals (10, 40 and 60 min.) after administration of the antidotes. Protective effect of trimedoxime decreased according to the following order: monocrotophos Ͼ heptenophos Ͼ dichlorvos. Administration of the oxime produced a significant reacti- vation of central and peripheral acetylcholinesterase inhibited with dichlorvos and heptenophos, with the exception of erythrocyte acetylcholinesterase inhibited by heptenophos. Surprisingly, trimedoxime did not induce reactivation of mon- ocrotophos-inhibited acetylcholinesterase in any of the tissues tested.
    [Show full text]
  • Acetylcholinesterase: the “Hub” for Neurodegenerative Diseases And
    Review biomolecules Acetylcholinesterase: The “Hub” for NeurodegenerativeReview Diseases and Chemical Weapons Acetylcholinesterase: The “Hub” for Convention Neurodegenerative Diseases and Chemical WeaponsSamir F. de A. Cavalcante Convention 1,2,3,*, Alessandro B. C. Simas 2,*, Marcos C. Barcellos 1, Victor G. M. de Oliveira 1, Roberto B. Sousa 1, Paulo A. de M. Cabral 1 and Kamil Kuča 3,*and Tanos C. C. França 3,4,* Samir F. de A. Cavalcante 1,2,3,* , Alessandro B. C. Simas 2,*, Marcos C. Barcellos 1, Victor1 Institute G. M. ofde Chemical, Oliveira Biological,1, Roberto Radiological B. Sousa and1, Paulo Nuclear A. Defense de M. Cabral (IDQBRN),1, Kamil Brazilian Kuˇca Army3,* and TanosTechnological C. C. França Center3,4,* (CTEx), Avenida das Américas 28705, Rio de Janeiro 23020-470, Brazil; [email protected] (M.C.B.); [email protected] (V.G.M.d.O.); [email protected] 1 Institute of Chemical, Biological, Radiological and Nuclear Defense (IDQBRN), Brazilian Army (R.B.S.); [email protected] (P.A.d.M.C.) Technological Center (CTEx), Avenida das Américas 28705, Rio de Janeiro 23020-470, Brazil; 2 [email protected] Mors Institute of Research (M.C.B.); on Natural [email protected] Products (IPPN), Federal (V.G.M.d.O.); University of Rio de Janeiro (UFRJ), CCS,[email protected] Bloco H, Rio de Janeiro (R.B.S.); 21941-902, [email protected] Brazil (P.A.d.M.C.) 32 DepartmentWalter Mors of Institute Chemistry, of Research Faculty of on Science, Natural Un Productsiversity (IPPN),
    [Show full text]
  • Medical Aspects of Chemical and Biological Warfare, Index
    Index INDEX A Aircrew uniform, integrated battlefield (AUIB), 373 Air delivery Aberdeen Proving Ground, Maryland, 398, 409–410 history, 28, 31, 34–35, 49–50 See also Edgewood Arsenal, Maryland See also Aerosol; Inhalational injury; specific agent ABG Airplane smoke tanks, 31 See Arterial blood gases (ABG) AIT Abortion See Aeromedical Isolation Team (AIT) septic, in brucellosis, 516 Alarms, 377–383 Abrin, 610, 632 biological agent, 431 Abrus precatorius, 610, 632 history, 23, 53, 60–62, 66–67 AC LOPAIR, E33 Area Scanning, 53 See Hydrogen cyanide (AC) M8A1 Automatic Chemical Agent, 380–381 Acetaminophen, 627 M21 Remote Sensing Chemical Agent (RSCAAL), 381 Acetylcholine (ACh), 132–134, 136, 159, 647 Portable Automatic Chemical Agent, 60–62 Acetylcholinesterase (AChE), 131–132, 134, 182–184 See also Detection Acetylene tetrachloride, 34 Alastrim, 543 Acid hydrolysis, 355 Alexander, Stewart, 103 Action potential, 133 Algal toxins, 457, 609, 617 Activated charcoal, 217, 362–363, 366, 370, 373, 670 Alimentary toxic aleukia (ATA), 659, 667 Adamsite Alkaline hydrolysis, 355 See DM (diphenylaminearsine) Allergic contact sensitivity, 238–239, 249, 314, 316–317 Additives, 122 a -Naphthylthiourea (ANTU), 638 Adenine arabinoside (Ara-A), 553 Alphaviruses, 562 Adenosine triphosphate (ATP), 275, 383, 431 antigenic classification, 564–565 S-Adenosylhomocysteine hydrolase inhibitors, 552 structure and replication, 569–570 Adenoviridae, 575, 683 See also Viral encephalitides; specific virus Adrenaline, 132 Alphavirus virion, 569 Adrenergic nervous system,
    [Show full text]
  • Pretreatment and Prophylaxis Against Nerve Agent Poisoning: Are Undesirable Behavioral Side Effects Unavoidable?
    1 Pretreatment and prophylaxis against nerve agent poisoning: Are undesirable behavioral side effects unavoidable? Trond Myhrer, Pål Aas Norwegian Defence Research Establishment (FFI), Protection and Societal Security Division, Kjeller, Norway Running title: Pretreatment and side effects Correspondence: Pål Aas Norwegian Defence Research Establishment (FFI) Protection and Societal Security Division P O Box 25 NO-2027 Kjeller, Norway Phone: +47 63 80 78 43 Fax: +47 63 80 75 09 E-mail: [email protected] 2 Abstract The threat of chemical warfare agents like nerve agents requires life saving measures of medical pretreatment combined with treatment after exposure. Pretreatment (pyridostigmine) may cause some side effects in a small number of individuals. A comprehensive research on animals has been performed to clarify effects on behavior. The results from these studies are far from unambiguous, since pyridostigmine may produce adverse effects on behavior in animals in relatively high doses, but not in a consistent way. Other animal studies have examined the potential of drugs like physostigmine, galantamine, benactyzine, trihexyphenidyl, and procyclidine, but they all produce marked behavioral impairment at doses sufficient to contribute to protection against a convulsant dose of soman. Attempts have also been made to develop a combination of drugs capable of assuring full protection (prophylaxis) against nerve agents. However, common to all combinations is that they at anticonvulsant doses cause behavioral deficits. Therefore, the use of limited pretreatment doses may be performed without marked side effects followed by post-exposure therapy with a combination of drugs. Keywords: Nerve agents; Pharmacological protection; Enzymatic protection; Behavioral side effects 3 1. Introduction Organophosphates called nerve agents are considered to be the most toxic among all chemical weapons.
    [Show full text]
  • On the Universality of Oxime Hlö-7 – Antidote for Case of the Nerve Agent Poisoning
    Mil. Med. Sci. Lett. (Voj. Zdrav. Listy) 2011, vol. 80, p. 80-84 ISSN 0372-7025 DOI: 10.31482/mmsl.2011.012 ORIGINAL ARTICLE ON THE UNIVERSALITY OF OXIME HLö-7 – ANTIDOTE FOR CASE OF THE NERVE AGENT POISONING Kamil Kuca 1,2 , Kamil Musilek 2,3 , Jana Karasova 2,4 , Daniel Jun 2, Ondrej Soukup 1,2 , Miroslav Pohanka 1,2 , Kallol Kumar Ghosh 5, Martina Hrabinova 1 1 Center of Advanced Studies, Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic 2 University Hospital, Hradec Kralove, Czech Republic 3 University of Hradec Kralove, Faculty of Science, Department of Chemistry, Hradec Kralove, Czech Republic 4 Department of Public Health, Faculty of Military Health Sciences, University of Defence, Hradec Kralove, Czech Republic 5 School of Studies in Chemistry, Pt. Ravishankar Shukla University, Raipur (C.G.), India Received 12 th April 2011. Revised 29 th May 2011. Published 10 th June 2011. Summary Searching for the universal oxime, which could be able to reactivate acetylcholinesterase inhibited by various nerve agents is still topic of high interest. In this contribution, oxime HLö-7, that was thoroughly discussed in the last decade, is evaluated . Its universality was tested in vitro using the rat brain homogenate as a source of the cholinesterases. The main members of the nerve agent family (tabun, sarin, soman, cyclosarin and VX) were used for this purpose. As shown, oxime HLö-7 was able to reactivate cholinesterases inhibited by all tested nerve agents with the exception of tabun. Hence, it could not be designated as the broad-spectrum reactivator.
    [Show full text]
  • In Vitro Evaluation of Neutral Aryloximes As Reactivators for Electrophorus Eel Acetylcholinesterase Inhibited by Paraoxon
    biomolecules Article In Vitro Evaluation of Neutral Aryloximes as Reactivators for Electrophorus eel Acetylcholinesterase Inhibited by Paraoxon Daniel A. S. Kitagawa 1,2 , Samir F. de A. Cavalcante 2,3,4,5,* , Reuel L. de Paula 2,6 , Rafael B. Rodrigues 2, Leandro B. Bernardo 2, Munique C. J. da Silva 2 , Thiago N. da Silva 4, Wellington V. dos Santos 7,8, José M. Granjeiro 6, Joyce S. F. D. de Almeida 1 , Marcos C. Barcellos 2, Ana Beatriz de A. Correa 2 , Tanos C. C. França 1,5 , Kamil Kuˇca 5,* and Alessandro B. C. Simas 3,* 1 Laboratory of Molecular Modelling Applied to Chemical and Biological Defense (LMACBD), Military Institute of Engineering (IME), Praça General Tibúrcio 80, Rio de Janeiro 22290-270, Brazil 2 Brazilian Army Institute of Chemical, Biological, Radiological and Nuclear Defense (IDQBRN), Brazilian Army Technological Center (CTEx), Avenida das Américas 28705, Rio de Janeiro 23020-470, Brazil 3 Walter Mors Institute of Research on Natural Products (IPPN), Federal University of Rio de Janeiro (UFRJ), CCS, Bloco H, Rio de Janeiro 21941-902, Brazil 4 Castelo Branco University (UCB), School of Pharmacy, Avenida Santa Cruz 1631, Rio de Janeiro 21710-255, Brazil 5 Department of Chemistry, Faculty of Science, University of Hradec Králové, Rokitanskeho 62, 50003 Hradec Králové, Czech Republic 6 National Institute of Metrology, Standardization and Industrial Quality (INMETRO), Avenida Nossa Senhora das Graças 50, Duque de Caxias 25250-020, Brazil 7 Emergency and Rescue Department (DSE), Rio de Janeiro State Fire Department (CBMERJ), Praça São Salvador 4, Rio de Janeiro 22231-170, Brazil 8 School of Biomedicine, University Universus Veritas (UNIVERITAS), Rua Marquês de Abrantes 55, Rio de Janeiro 22230-060, Brazil * Correspondence: [email protected] (S.F.d.A.C.); [email protected] (K.K.); [email protected] (A.B.C.S.) Received: 9 September 2019; Accepted: 4 October 2019; Published: 8 October 2019 Abstract: Casualties caused by organophosphorus pesticides are a burden for health systems in developing and poor countries.
    [Show full text]
  • In Vitro Ability of Currently Available Oximes to Reactivate Organophosphate Pesticide-Inhibited Human Acetylcholinesterase and Butyrylcholinesterase
    Int. J. Mol. Sci. 2011, 12, 2077-2087; doi:10.3390/ijms12032077 OPEN ACCESS International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms Article In Vitro Ability of Currently Available Oximes to Reactivate Organophosphate Pesticide-Inhibited Human Acetylcholinesterase and Butyrylcholinesterase Daniel Jun 1,2,3,*, Lucie Musilova 4,5, Kamil Musilek 6 and Kamil Kuca 1,* 1 Center of Advanced Studies, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, Hradec Kralove, 500 01, Czech Republic 2 Department of Water Resources and Environmental Modeling, Faculty of Environmental Sciences, Czech University of Life Sciences Prague, Kamycka 129, Praha 6—Suchdol, 16521, Czech Republic 3 University Hospital Hradec Kralove, Sokolska 581, Hradec Kralove, 50005, Czech Republic 4 Hospital Pharmacy, University Hospital Hradec Kralove, Sokolska 581, Hradec Kralove, 500 05, Czech Republic; E-Mail: [email protected] 5 Department of Biochemical Sciences, Charles University in Prague, Faculty of Pharmacy in Hradec Kralove, Heyrovskeho 1203, Hradec Kralove, 50005, Czech Republic 6 Department of Toxicology, Faculty of Military Health Sciences, University of Defence, Trebesska 1575, Hradec Kralove, 50001, Czech Republic; E-Mail: [email protected] * Authors to whom correspondence should be addressed; E-Mails: [email protected] (D.J.); [email protected] (K.K.); Tel.: +420-973-255-193; Fax: +420-495-518-094. Received: 11 February 2011 / Accepted: 9 March 2011 / Published: 23 March 2011 Abstract: We have in vitro tested the ability of common, commercially available, cholinesterase reactivators (pralidoxime, obidoxime, methoxime, trimedoxime and HI-6) to reactivate human acetylcholinesterase (AChE), inhibited by five structurally different organophosphate pesticides and inhibitors (paraoxon, dichlorvos, DFP, leptophos-oxon and methamidophos).
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2009/0023706 A1 Albuquerque Et Al
    US 20090023706A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2009/0023706 A1 Albuquerque et al. (43) Pub. Date: Jan. 22, 2009 (54) METHOD OF TREATING Related U.S. Application Data ORGANOPHOSPHOROUS POISONING (63) Continuation-in-part of application No. 1 1/575.945, filed on May 23, 2007, filed as application No. PCT/ (75) Inventors: Edson X. Albuquerque, Baltimore, US05/33789 on Sep. 23, 2005. MD (US); Michael Adler, Bel Air, (60) Provisional application No. 60/613,121, filed on Sep. MD (US); Edna F.R. Pereira, 24, 2004. Baltimore, MD (US) Publication Classification (51) Int. Cl. Correspondence Address: A6II 3/55 2006.O1 EVANS & MOLINELLI, PLLC (52) U.S. Cl ( .01) S14/215 U.S. POST OFFICE BOX 7024 Oa - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - FAIRFAX STATION, VA 22039 (US) (57) ABSTRACT The present invention is directed to various methods for treat (73) Assignee: University of Maryland ing organophosphorus poisoning in an animal that is at risk of Baltimore, Baltimore, MD (US) exposure to an organophosphorus compound or preventing organophosphorus poisoning in an animal that has been exposed to an organophosphorus compound, by administer (21) Appl. No.: 12/199,250 ingatherapeutically effective amount of galantamine or a salt thereof, or a biologically active analog, derivative, fragment (22) Filed: Aug. 27, 2008 or variant thereof. A Soman, 1.5xLD50 B. Sarin, 1.5xLD50 C Soman, 1.5xLD50 25 Atropine, 10 mg/kg Atropine, 10 mg/kg Galantamine, 5 mg/kg O Galantamine, 8 mg/kg Y. P. ... First O. 1 10 O. 1 10 1 10 100 Galantamine, mg/kg Galantamine, mg/kg Atropine, mg/kg Patent Application Publication Jan.
    [Show full text]
  • Efficacious Oxime for Organophosphorus Poisoning: a Minireview
    Nurulain Tropical Journal of Pharmaceutical Research June 2011; 10 (3): 341-349 © Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, 300001 Nigeria. All rights reserved . Available online at http://www.tjpr.org DOI: 10.4314/tjpr.v10i3.10 Review Article Efficacious Oxime for Organophosphorus Poisoning: A Minireview Syed M Nurulain Department of Pharmacology and Therapeutics, Faculty of Medicine and Health Sciences, United Arab Emirates University, PO Box 17666, AlAin, United Arab Emirate Abstract Oximes are well known as acetylcholinesterase reactivators and are used in organophosphorus poisoning to reactivate inhibited acetylcholinesterase. Therapeutically available oximes, namely, pralidoxime (2-PAM), obidoxime, trimedoxime and Hagedorn oxime (HI-6), have no broad-spectrum activity against structurally different kinds of organophosphorus anticholinesterases. The widely used oxime, 2-PAM, is least effective. The focus of the review is to find an oxime that is broad spectrum and superior to the presently available oximes for the treatment of organophosphorus poisoning. Numerous oxime-based reactivators have been synthesized - in laboratories in Croatia, United States of America, Israel and most recently in Czech Republic. Some experimental oximes synthesized in Czech Republic and named as K-series of oximes have been found promising. Among them, K-27 and K-48 have higher or comparable efficacy to all available oximes though it is not effective against all organophosphorus (OP) nerve agents. They are also efficacious in pretreatment protocol for OP anticholinesterases. K-27 oxime is a promising candidate to replace therapeutically available oximes with respect to insecticide/pesticide organophosphorus poisoning. K27 and K48 may be candidates to replace the only approved pretreatment drug, pyridostigmine, in military combat medicine for OP nerve agent.
    [Show full text]
  • C:\Documents and Settings\Doktorová\Plocha\JAB
    Journal of J Appl Biomed 8:35–40, 2010 DOI 10.2478/v10136-009-0005-9 APPLIED ISSN 1214-0287 BIOMEDICINE ORIGINAL ARTICLE In vitro screening of blood-brain barrier penetration of clinically used acetylcholinesterase reactivators Jana Žďárová Karasová1, Petr Stodůlka2, Kamil Kuča1, 2 1Department of Toxicology, 2Center of Advanced Studies, Faculty of Military Health Sciences, University of Defence, Hradec Králové, Czech Republic Received 23rd June 2009. Revised 10th September 2009. Published online 8th December 2009. Summary In this in vitro study, using the HPLC method, we determined the ability of acetylcholinesterase (AChE) reactivators, used clinically, to penetrate the blood-brain barrier (BBB). We evaluated pralidoxime, HI-6, obidoxime, trimedoxime and methoxime – reactivators varying in the position of the oxime group on the pyridinium ring and linker connecting the pyridinium rings. Our results indicated that pralidoxime, a monoquaternary AChE reactivator, was the oxime with the most penetration. Molecular weight seems to be the most important factor for passive transport through the BBB. From the structural perspective, the connecting linker also plays a key role in the ability of the reactivators to penetrate the CNS. In this case, the simple and short linker is favorable for permeation of these compounds. The location of the oxime group on the pyridine ring may also influence passive transport into the brain; the best position of the oxime group seems to be position four. Key words: blood-brain barrier; CNS penetration; HI-6; obidoxime; HPLC; oxime INTRODUCTION on the pyridinium ring and in the linker connecting the pyridinium rings (Kuča et al. 2006). Some mono- The basis of the current standard treatment of and also bisquaternary pyridinium oximes are more or organophosphate (OP) poisoning is the administration less frequently used in clinical practice.
    [Show full text]
  • Antioxidant Markers in Guinea Pig Exposed to Obidoxime and HI-6 Acetylcholinesterase Oxime Reactivators Containing Oxime Moiety
    Vol. 7(31), pp. 2252-2257, 22 August, 2013 DOI 10.5897/AJPP12.438 African Journal of Pharmacy and ISSN 1996-0816 ©2013 Academic Journals http://www.academicjournals.org/AJPP Pharmacology Full Length Research Paper Antioxidant markers in guinea pig exposed to obidoxime and HI-6 acetylcholinesterase oxime reactivators containing oxime moiety Lucie Drtinova and Miroslav Pohanka* Faculty of Military Health Sciences, University of Defense, Trebesska 1575, 50001, Hradec Kralove, Czech Republic. Accepted 10 August, 2012 Obidoxime and asoxime (HI-6) are considered to be the most important acetylcholinesterase (AChE) reactivators applicable for treatment of poisoning by nerve agents. Unfortunately, toxicology of the oximes is not well known. For this reason, we decided to investigate the pertinent adverse effects on guinea pigs which are close to humans in toxicological point of view. HI-6 and obidoxime were administered intramuscularly in 5% of the median lethal dose. The animals were sacrificed 15, 30, 60, 120, and 240 min after exposure, and the brain, liver, spleen and kidneys were collected. Ferric reducing antioxidant power (FRAP), thiobarbituric acid reactive substances (TBARS), glutathione S-transferase (GST) and glutathione reductase (GR) were measured. Results indicated that obidoxime acted on oxidative stress than HI-6. We found evidence of low molecular weight antioxidants depletion after obidoxime administration. On the other hand, TBARS assay showed significant decrease in brain and little increase in spleen and liver. The effect of HI-6 was more striking than the effect of obidoxime. There was a sign of higher metabolism and production of antioxidants in liver because GR was significantly increased after HI-6 exposure, and it is another sign of ongoing oxidative stress.
    [Show full text]
  • Nerve Agents
    J R Army Med Corps 2002; 148: 344-357 J R Army Med Corps: first published as 10.1136/jramc-148-04-04 on 1 December 2002. Downloaded from Nerve Agents Introduction persistent. It is regarded as presenting little The nerve agents (NA) are a group of vapour hazard to people exposed to it. In the particularly toxic chemical warfare agents. pure state nerve agents are colourless and They were developed just before and during mobile liquids. In an impure state, nerve World War II. Although chemically related to agents may be encountered as yellowish to the organophosphorus insecticides, their brown liquids. Some nerve agents have a clinical presentation and medical faint fruity odour. management may differ. The principal nerve In general, nerve agents are moderately agents are: GA (tabun), GB (sarin), GD soluble in water with slow hydrolysis, highly (soman), GF (cyclosarin) and VX soluble in lipids, and are rapidly inactivated (methylphosphonothioic acid). In some by strong alkalis and chlorinating countries the "V" agents are known as "A" compounds. agents. Detection Physical and Chemical Nerve agents may be detected by a variety of Properties means. Single and three colour detector Nerve agents are organophosphorus esters. papers are available for individual issue to The "G" agents tend to be non-persistent detect liquid nerve agent. Area detectors and whereas the "V" agents are persistent. Some monitors of various sensitivities are available agents may be thickened in order to increase (Figures 9,10,11). Highly sensitive and their persistence, and therefore the total specific water testing kits are also available. amount penetrating intact skin.
    [Show full text]